During neoplasm development in the mammary gland, the application of colony‐stimulating factor 1 receptor (CSF1‐R) inhibitors can deplete TAMs to effectively inhibit metastasis, angiogenesis and reduce the invasiveness of the tumor.19 Here, CSF1R is linked to neoplasm.